Barclays’s SCYNEXIS SCYX Stock Holding History

Barclays’s Portfolio SCYX Stock Details SCYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10	Sell	2 -289	-99%	-$1.37K	﹤0.01%	5180
2026 Q2	$1.18K	Buy	+291	New	+$1.81K	﹤0.01%	4916
2020 Q1	–	Hold	0	–	–	–	6423
2019 Q4	–	Hold	0	–	–	–	6754
2018 Q2	–	Hold	0	–	–	–	7244
2018 Q1	–	Hold	0	–	–	–	7294

Other funds holding SCYX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Barclays's SCYX Position: Q3 2026 in Review

Barclays reduced its SCYNEXIS (SCYX) stake by 99% in Q3 2026, selling an estimated $1.37K and leaving 2 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #5180.

Barclays first reported a position in SCYX in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.18K in Q2 2026. 7 funds tracked by Wall St. Rank hold SCYX as of Q3 2026.

Barclays held 2 shares of SCYNEXIS worth $10 as of Q3 2026.
Barclays sold 289 SCYNEXIS shares in Q3 2026, an estimated $1.37K.
SCYNEXIS made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5180 holding.
Barclays first reported a position in SCYNEXIS in Q2 2026 and has held it in 2 quarters since.
Barclays's SCYNEXIS position peaked at $1.18K in Q2 2026.
7 funds tracked by Wall St. Rank held SCYNEXIS as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.